TY - JOUR AU - Chang, G. W. M. AU - Kam, P. C. A. PY - 1999 DA - 1999// TI - The physiological and pharmacological roles of cytochrome P450 isoenzymes JO - Anaesthesia VL - 54 UR - https://doi.org/10.1046/j.1365-2044.1999.00602.x DO - 10.1046/j.1365-2044.1999.00602.x ID - Chang1999 ER - TY - JOUR AU - Ingelman-Sundberg, M. PY - 2005 DA - 2005// TI - The human genome project and novel aspects of cytochrome P450 research JO - Toxicol. Appl. Pharmacol. VL - 207 UR - https://doi.org/10.1016/j.taap.2005.01.030 DO - 10.1016/j.taap.2005.01.030 ID - Ingelman-Sundberg2005 ER - TY - JOUR AU - Burroughs, V. J. AU - Maxey, R. W. AU - Levy, R. A. PY - 2002 DA - 2002// TI - Racial and ethnic differences in response to medicines: toward individualized pharmaceutical treatment JO - J. Natl. Med. Assoc. VL - 94 ID - Burroughs2002 ER - TY - JOUR AU - Ingelman-Sundberg, M. PY - 2005 DA - 2005// TI - Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity JO - Pharmacogenomics J. VL - 5 UR - https://doi.org/10.1038/sj.tpj.6500285 DO - 10.1038/sj.tpj.6500285 ID - Ingelman-Sundberg2005 ER - TY - JOUR AU - Scordo, M. A. AU - Caputi, A. P. AU - D’Arrigo, C. AU - Fava, G. AU - Spina, E. PY - 2004 DA - 2004// TI - Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population JO - Pharmacol. Res. VL - 50 UR - https://doi.org/10.1016/j.phrs.2004.01.004 DO - 10.1016/j.phrs.2004.01.004 ID - Scordo2004 ER - TY - JOUR AU - Ingelman-Sundberg, M. PY - 2004 DA - 2004// TI - Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future JO - Trends Pharmacol. Sci. VL - 25 UR - https://doi.org/10.1016/j.tips.2004.02.007 DO - 10.1016/j.tips.2004.02.007 ID - Ingelman-Sundberg2004 ER - TY - JOUR AU - Saxena, R. PY - 1994 DA - 1994// TI - Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with poor metabolizer phenotype JO - Hum. Mol. Gen. VL - 3 UR - https://doi.org/10.1093/hmg/3.6.923 DO - 10.1093/hmg/3.6.923 ID - Saxena1994 ER - TY - JOUR AU - Sachse, C. AU - Brockmoller, J. AU - Bauer, S. AU - Roots, I. PY - 1997 DA - 1997// TI - Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences JO - Am. J. Hum. Genet. VL - 60 ID - Sachse1997 ER - TY - JOUR AU - Weide, J. AU - Steijns, L. PY - 1999 DA - 1999// TI - Cytochrome P450 enzyme system: genetic polymorphisms and impact on clinical pharmacology JO - Ann. Clin. Biochem. VL - 36 UR - https://doi.org/10.1177/000456329903600604 DO - 10.1177/000456329903600604 ID - Weide1999 ER - TY - JOUR AU - Batlle, C. A. M. PY - 1997 DA - 1997// TI - Porfirinas y porfirias: aspectos clínicos, bioquímicos y biología molecular. Serie: Actualizaciones Médico-Bioquímicas JO - Acta Bioquím. Latinoamer. VL - 3 ID - Batlle1997 ER - TY - JOUR AU - Nordmann, Y. AU - Puy, H. AU - Deybach, J. C. PY - 1999 DA - 1999// TI - The porphyrias JO - J. Hepatol. VL - 30 ID - Nordmann1999 ER - TY - JOUR AU - Thadani, H. AU - Deacon, A. AU - Peters, T. PY - 2000 DA - 2000// TI - Diagnosis and management of porphyria JO - Br. Med. J. VL - 320 UR - https://doi.org/10.1136/bmj.320.7250.1647 DO - 10.1136/bmj.320.7250.1647 ID - Thadani2000 ER - TY - JOUR AU - Meyer, U. A. AU - Schuurmans, M. M. AU - Lindberg, R. L. PY - 1998 DA - 1998// TI - A review of the pathogenesis of the neurological manifestations of the acute porphyrias JO - Semin. Liver Dis. VL - 18 UR - https://doi.org/10.1055/s-2007-1007139 DO - 10.1055/s-2007-1007139 ID - Meyer1998 ER - TY - JOUR AU - Méndez, M. AU - Rossetti, M. V. AU - Batlle, C. A. M. AU - Parera, V. E. PY - 2005 DA - 2005// TI - The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population JO - J. Am. Acad. Dermatol. VL - 52 UR - https://doi.org/10.1016/j.jaad.2004.09.014 DO - 10.1016/j.jaad.2004.09.014 ID - Méndez2005 ER - TY - JOUR AU - Daly, A. K. AU - Steen, V. M. AU - Fairbrother, K. S. AU - Idle, J. R. PY - 1996 DA - 1996// TI - CYP2D6 Multiallelism JO - Methods in Enzymology: Cytochrome P450 VL - 272 UR - https://doi.org/10.1016/S0076-6879(96)72024-4 DO - 10.1016/S0076-6879(96)72024-4 ID - Daly1996 ER - TY - JOUR AU - Lennard, M. S. PY - 1990 DA - 1990// TI - Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal JO - Pharmacol. Toxicol. VL - 67 UR - https://doi.org/10.1111/j.1600-0773.1990.tb00830.x DO - 10.1111/j.1600-0773.1990.tb00830.x ID - Lennard1990 ER - TY - JOUR AU - Bertilsson, L. AU - Dahl, M. L. AU - Dalen, P. AU - Al-Shurbaji, A. PY - 2002 DA - 2002// TI - Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs JO - Br. J. Clin. Pharmacol. VL - 53 UR - https://doi.org/10.1046/j.0306-5251.2001.01548.x DO - 10.1046/j.0306-5251.2001.01548.x ID - Bertilsson2002 ER - TY - JOUR AU - Marez, D. PY - 1997 DA - 1997// TI - Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution JO - Pharmacogenetics VL - 7 UR - https://doi.org/10.1097/00008571-199706000-00004 DO - 10.1097/00008571-199706000-00004 ID - Marez1997 ER - TY - JOUR AU - Bradford, L. D. PY - 2002 DA - 2002// TI - CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants JO - Pharmacogenomics VL - 3 UR - https://doi.org/10.1517/14622416.3.2.229 DO - 10.1517/14622416.3.2.229 ID - Bradford2002 ER - TY - JOUR AU - Meyer, U. A. AU - Zanger, U. M. PY - 1997 DA - 1997// TI - Molecular mechanisms of genetic polymorphisms of drug metabolism JO - Annu. Rev. Pharmacol. Toxicol. VL - 37 UR - https://doi.org/10.1146/annurev.pharmtox.37.1.269 DO - 10.1146/annurev.pharmtox.37.1.269 ID - Meyer1997 ER - TY - JOUR AU - Cascorbi, I. PY - 2003 DA - 2003// TI - Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication JO - Eur. J. Clin. Invest. VL - 33 UR - https://doi.org/10.1046/j.1365-2362.33.s2.3.x DO - 10.1046/j.1365-2362.33.s2.3.x ID - Cascorbi2003 ER - TY - JOUR AU - Caporaso, N. AU - Landi, M. T. AU - Vineis, P. PY - 1991 DA - 1991// TI - Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence JO - Pharmacogenetics VL - 1 UR - https://doi.org/10.1097/00008571-199110000-00003 DO - 10.1097/00008571-199110000-00003 ID - Caporaso1991 ER - TY - JOUR AU - Agündez, J. A. PY - 1994 DA - 1994// TI - Debrisoquin oxidation genotype and susceptibility to lung cancer JO - Clin. Pharmacol. Ther. VL - 55 UR - https://doi.org/10.1038/clpt.1994.3 DO - 10.1038/clpt.1994.3 ID - Agündez1994 ER - TY - JOUR AU - Anwar, W. A. AU - Abdel-Rahman, S. Z. AU - El-Zein, R. A. AU - Mostafa, H. M. AU - Au, W. W. PY - 1996 DA - 1996// TI - Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients JO - Carcinogenesis VL - 17 UR - https://doi.org/10.1093/carcin/17.9.1923 DO - 10.1093/carcin/17.9.1923 ID - Anwar1996 ER - TY - JOUR AU - Agündez, J. A. AU - Ledesma, M. C. AU - Benitez, J. M. AU - Ladero, J. M. AU - Rodriguez-Lescure, A. AU - Diaz-Rubio, E. AU - Diaz-Rubio, M. PY - 1995 DA - 1995// TI - CYP2D6 genes and risk of liver cancer JO - Lancet VL - 345 UR - https://doi.org/10.1016/S0140-6736(95)92965-7 DO - 10.1016/S0140-6736(95)92965-7 ID - Agündez1995 ER - TY - JOUR AU - Wolf, C. R. PY - 1992 DA - 1992// TI - Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility JO - Carcinogenesis VL - 13 UR - https://doi.org/10.1093/carcin/13.6.1035 DO - 10.1093/carcin/13.6.1035 ID - Wolf1992 ER - TY - JOUR AU - Anthony, L. B. AU - Thomas, J. B. AU - Hande, K. R. PY - 1995 DA - 1995// TI - Cytochrome P-450IID6 phenotyping in cancer patients: debrisoquine and dextromethorphan as probes JO - Cancer Chemother. Pharmacol. VL - 36 UR - https://doi.org/10.1007/BF00689196 DO - 10.1007/BF00689196 ID - Anthony1995 ER - TY - JOUR AU - Topic, E. AU - Stefanovic, M. AU - Ivanisevic, A. M. AU - Petrinovic, R. AU - Curcic, I. PY - 2000 DA - 2000// TI - The cytochrome P450 2D6 (CYP2D6) gene polymorphism among breast and head and neck cancer patients JO - Clin. Chim. Acta VL - 296 UR - https://doi.org/10.1016/S0009-8981(00)00221-7 DO - 10.1016/S0009-8981(00)00221-7 ID - Topic2000 ER - TY - JOUR AU - Gardlo, K. AU - Selimovic, D. AU - Bolsen, K. AU - Ruzicka, T. AU - Abel, J. AU - Fritsch, C. PY - 2003 DA - 2003// TI - Cytochrome P4501A1 polymorphisms in a Caucasian population with porphyria JO - Exp. Dermatol. VL - 12 UR - https://doi.org/10.1111/j.0906-6705.2003.00095.x DO - 10.1111/j.0906-6705.2003.00095.x ID - Gardlo2003 ER - TY - JOUR AU - Christiansen, L. AU - Bygum, A. AU - Jensen, A. AU - Thomsen, K. AU - Brandrup, F. AU - Horder, M. AU - Petersen, N. E. PY - 2000 DA - 2000// TI - Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda JO - Hum. Genet. VL - 107 UR - https://doi.org/10.1007/s004390000415 DO - 10.1007/s004390000415 ID - Christiansen2000 ER - TY - JOUR AU - Spear, B. AU - Heath-Chiozzi, M. AU - Huff, J. PY - 2001 DA - 2001// TI - Clinical application of pharmacogenetics JO - Trend Mol. Med. VL - 7 UR - https://doi.org/10.1016/S1471-4914(01)01986-4 DO - 10.1016/S1471-4914(01)01986-4 ID - Spear2001 ER -